Ditemukan 3 dokumen yang sesuai dengan query :: Simpan CSV
Wina Adelia Putri; Pembimbing: Besral; Penguji: Milla Herdayati, Zakiah
Abstrak:
Latar Belakang: Hipertensi merupakan salah satu beban kesehatan masyarakat terbesar di Indonesia dan pemicu utama penyakit kardiovaskular. Keberhasilan pengendalian kondisi hipertensi sangat bergantung pada kepatuhan pasien. Berdasarkan data SKI 2023, ketidakpatuhan minum obat antihipertensi masih menjadi masalah signifikan di Indonesia. Metode: Menggunakan data sekunder dari SKI 2023 dengan desain studi cross sectional. Sampel adalah responden berusia ≥18 tahun dengan diagnosis hipertensi. Responden dengan data tidak lengkap dan wanita hamil diesklusi sehingga menghasilkan sampel akhir sebanyak 49.026 responden. Analisis data menggunakan regresi logistik multinomial. Hasil: Seluruh variabel independen yang diuji (pendidikan, pekerjaan, status ekonomi, wilayah geografis, komorbiditas, waktu sejak diagnosis, umur, jenis kelamin, tempat tinggal, perilaku penggunaan obat tradisional, konsumsi alkohol, akses fasilitas kesehatan, kepemilikan asuransi, dan dukungan informasi) berhubungan signifikan dengan ketidakpatuhan. Persentase ketidakpatuhan adalah sebesar 53,5%, yaitu 36,7% (95% CI: 35,9-37,4) responden tidak rutin dan 16,8% (95% CI: 16,2-17,4) tidak minum obat. AOR tertinggi ditemukan pada responden yang tidak mendapatkan dukungan informasi, baik pada kategori tidak rutin (AOR 3,76; 95% CI 3,59-3,95; p<0,001) dan pada kategori tidak minum obat (AOR 8,63; 95% CI: 8,12-9,19; p<0,001). Kesimpulan: Ketidakpatuhan minum obat antihipertensi masih menjadi tantangan besar di Indonesia. Diperlukan intervensi berbasis komunitas, peningkatan edukasi, dan perbaikan akses kesehatan untuk meningkatkan kepatuhan terhadap pengobatan.
Background: Hypertension is one of the largest public health burdens in Indonesia and a major trigger for cardiovascular disease. The success of controlling hypertension is highly dependent on patient compliance. Based on SKI 2023 data, non-compliance with taking antihypertensive drugs is still a significant problem in Indonesia. Methods: Using secondary data from SKI 2023 with a cross-sectional study design. The sample was respondents aged ≥18 years with a diagnosis of hypertension. Respondents with incomplete data and pregnant women were excluded, resulting in a final sample of 49,026 respondents. Data analysis used multinomial logistic regression. Results: All independent variables tested (education, occupation, economic status, geographic region, comorbidities, time since diagnosis, age, gender, place of residence, traditional medicine use behavior, alcohol consumption, access to health facilities, insurance ownership, and information support) were significantly associated with non-compliance. The percentage of non-compliance was 53.5%, specifically 36.7% (95% CI: 35.9-37.4) of respondents did not follow the routine, and 16.8% (95% CI: 16.2-17.4) did not take their medication. The highest AOR was found in respondents who did not receive information support, both in the non-routine category (AOR 3.76; 95% CI 3.59-3.95; p<0.001) and in the category of not taking medication (AOR 8.63; 95% CI: 8.12-9.19; p<0.001). Conclusion: Non-compliance with taking antihypertensive medication is still a major challenge in Indonesia. Community-based interventions, increased education, and improved access to health are needed to improve treatment adherence.
Read More
Background: Hypertension is one of the largest public health burdens in Indonesia and a major trigger for cardiovascular disease. The success of controlling hypertension is highly dependent on patient compliance. Based on SKI 2023 data, non-compliance with taking antihypertensive drugs is still a significant problem in Indonesia. Methods: Using secondary data from SKI 2023 with a cross-sectional study design. The sample was respondents aged ≥18 years with a diagnosis of hypertension. Respondents with incomplete data and pregnant women were excluded, resulting in a final sample of 49,026 respondents. Data analysis used multinomial logistic regression. Results: All independent variables tested (education, occupation, economic status, geographic region, comorbidities, time since diagnosis, age, gender, place of residence, traditional medicine use behavior, alcohol consumption, access to health facilities, insurance ownership, and information support) were significantly associated with non-compliance. The percentage of non-compliance was 53.5%, specifically 36.7% (95% CI: 35.9-37.4) of respondents did not follow the routine, and 16.8% (95% CI: 16.2-17.4) did not take their medication. The highest AOR was found in respondents who did not receive information support, both in the non-routine category (AOR 3.76; 95% CI 3.59-3.95; p<0.001) and in the category of not taking medication (AOR 8.63; 95% CI: 8.12-9.19; p<0.001). Conclusion: Non-compliance with taking antihypertensive medication is still a major challenge in Indonesia. Community-based interventions, increased education, and improved access to health are needed to improve treatment adherence.
S-11968
Depok : FKM-UI, 2025
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Dinda Ayu Reihanisa; Pembimbing: Sudijanto Kamso; Penguji: Popy Yuniar, Rahmadewi
S-11970
Depok : FKM-UI, 2025
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Bintang Sukma Dhea Fransisca Enjellita; Pembimbing: Nurhayati Adnan; Penguji: Helda, Dewi Kristanti
Abstrak:
Read More
Latar belakang: Hipertensi menjadi penyebab kematian dini tertinggi di seluruh dunia dan merupakan faktor risiko utama untuk penyakit kardiovaskular termasuk di Indonesia. Jawa Barat merupakan provinsi dengan angka prevalensi hipertensi tertinggi di Indonesia yaitu sebesar 34,4% berdasarkan hasil pengukuran tekanan darah dan sebesar 10,7% berdasarkan diagnosis dokter yang menjadikan Jawa Barat sebagai provinsi terbesar ketiga dengan prevalensi hipertensi terbanyak pada penduduk berusia ≥ 18 tahun. Dalam penanganan penyakit hipertensi, indikator terkait terapi atau pengobatan hipertensi merupakan salah satu faktor yang penting untuk diperhatikan. Data terbaru yang diperoleh dari Survei Kesehatan Indonesia (SKI) tahun 2023 menunjukkan bahwa ketidakpatuhan konsumsi obat antihipertensi di Jawa Barat mencapai 53,8% dengan 35,5% pasien tidak teratur minum obat dan 18,3% tidak minum obat sama sekali. Rendahnya kepatuhan pasien hipertensi untuk konsumsi obat antihipertensi masih menjadi masalah dalam penanganan hipertensi di Indonesia terutama di Jawa Barat. Tujuan: Penelitian ini bertujuan untuk mengetahui faktor-faktor yang berhubungan dengan ketidakpatuhan konsumsi obat antihipertensi pada pasien hipertensi berusia ≥ 18 tahun di Jawa Barat. Metode: Penelitian ini menggunakan desain studi cross-sectional dengan analisis univariat dan bivariat. Hasil: Prevalensi ketidakpatuhan konsumsi obat antihipertensi pada pasien hipertensi usia ≥ 18 tahun di Jawa Barat adalah 53,1% dengan “merasa sudah sehat” menjadi alasan tertinggi ketidakpatuhan. Faktor yang signifikan berhubungan dengan ketidakpatuhan konsumsi obat antihipertensi meliputi berusia 18 - 59 tahun (PR = 1,23; 95% CI = 1,06 - 1,47), memiliki tingkat pendidikan rendah (PR = 1,17; 95% CI = 1,09 - 1,27), tidak memiliki jaminan kesehatan (PR = 1,26; 95% CI = 1,18 - 1,36), merokok (PR = 1,12; 95% CI = 1,04 - 1,21), tidak memiliki pengetahuan terkait konsumsi obat antihipertensi (PR = 1,88; 95% CI = 1,72 - 1,97). Kesimpulan: Pemerintah perlu meningkatkan edukasi kesehatan dan menekankan pentingnya rutin mengonsumsi obat antihipertensi meskipun tidak merasakan gejala. Selain itu, diperlukan kerja sama lintas sektor untuk mendukung pencegahan ketidakpatuhan konsumsi obat antihipertensi.
Background: Hypertension is the leading cause of premature death worldwide and is a major risk factor for cardiovascular diseases, including in Indonesia. West Java is the province with the highest prevalence of hypertension in Indonesia, with a rate of 34.4% based on blood pressure measurements and 10.7% based on doctor diagnoses. This makes West Java the third largest province in terms of hypertension prevalence among individuals aged ≥ 18 years. In managing hypertension, indicators related to hypertension therapy or medication are crucial factors that need attention. Recent data from the Indonesia Health Survey (SKI) shows that non-adherence to antihypertensive medication in West Java reaches 53.8%, with 35.5% of patients taking medication irregularly and 18.3% not taking medication at all. The low level of adherence among hypertensive patients to taking antihypertensive medication remains a significant issue in hypertension management in Indonesia, particularly in West Java. Objective: This study aims to identify the factors associated with non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java. Methods: This research used a cross-sectional study design with univariate and bivariate analyses. Results: The prevalence of non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java is 53.1%, with “feeling healthy” being the most common reason for non-adherence. Significant factors associated with non-adherence to antihypertensive medication include: being aged 18–59 years (PR = 1.23; 95% CI = 1.06–1.47), having a low education level (PR = 1.17; 95% CI = 1.09–1.27), lacking health insurance (PR = 1.26; 95% CI = 1.18–1.36), smoking (PR = 1.12; 95% CI = 1.04–1.21), and lacking knowledge related to antihypertensive medication (PR = 1.88; 95% CI = 1.72–1.97). Conclusion: The government needs to enhance health education and emphasize the importance of regularly taking antihypertensive medication, even when no symptoms are present. Additionally, cross-sector collaboration is necessary to support the prevention of non-adherence to antihypertensive medication.
Background: Hypertension is the leading cause of premature death worldwide and is a major risk factor for cardiovascular diseases, including in Indonesia. West Java is the province with the highest prevalence of hypertension in Indonesia, with a rate of 34.4% based on blood pressure measurements and 10.7% based on doctor diagnoses. This makes West Java the third largest province in terms of hypertension prevalence among individuals aged ≥ 18 years. In managing hypertension, indicators related to hypertension therapy or medication are crucial factors that need attention. Recent data from the Indonesia Health Survey (SKI) shows that non-adherence to antihypertensive medication in West Java reaches 53.8%, with 35.5% of patients taking medication irregularly and 18.3% not taking medication at all. The low level of adherence among hypertensive patients to taking antihypertensive medication remains a significant issue in hypertension management in Indonesia, particularly in West Java. Objective: This study aims to identify the factors associated with non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java. Methods: This research used a cross-sectional study design with univariate and bivariate analyses. Results: The prevalence of non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java is 53.1%, with “feeling healthy” being the most common reason for non-adherence. Significant factors associated with non-adherence to antihypertensive medication include: being aged 18–59 years (PR = 1.23; 95% CI = 1.06–1.47), having a low education level (PR = 1.17; 95% CI = 1.09–1.27), lacking health insurance (PR = 1.26; 95% CI = 1.18–1.36), smoking (PR = 1.12; 95% CI = 1.04–1.21), and lacking knowledge related to antihypertensive medication (PR = 1.88; 95% CI = 1.72–1.97). Conclusion: The government needs to enhance health education and emphasize the importance of regularly taking antihypertensive medication, even when no symptoms are present. Additionally, cross-sector collaboration is necessary to support the prevention of non-adherence to antihypertensive medication.
S-12011
Depok : FKM-UI, 2025
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉